31,584 Shares in Humana Inc. (NYSE:HUM) Acquired by Quantbot Technologies LP

Quantbot Technologies LP acquired a new stake in Humana Inc. (NYSE:HUM) in the 3rd quarter, Holdings Channel reports. The institutional investor acquired 31,584 shares of the insurance provider’s stock, valued at approximately $10,004,000. Humana accounts for about 0.4% of Quantbot Technologies LP’s portfolio, making the stock its 29th largest position.

A number of other institutional investors have also recently made changes to their positions in HUM. FMR LLC increased its stake in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares during the period. Qsemble Capital Management LP purchased a new position in shares of Humana in the third quarter valued at about $1,515,000. Bank of Montreal Can raised its stake in shares of Humana by 18.4% during the third quarter. Bank of Montreal Can now owns 189,168 shares of the insurance provider’s stock valued at $60,452,000 after acquiring an additional 29,460 shares during the last quarter. Independent Advisor Alliance boosted its holdings in shares of Humana by 68.3% during the third quarter. Independent Advisor Alliance now owns 2,141 shares of the insurance provider’s stock worth $678,000 after purchasing an additional 869 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Humana during the third quarter worth about $404,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research analyst reports. Piper Sandler cut Humana from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and dropped their price target for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. KeyCorp began coverage on shares of Humana in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. TD Cowen raised their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target on the stock in a research report on Tuesday, October 8th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $315.86.

Humana Price Performance

Shares of NYSE:HUM opened at $304.18 on Tuesday. The business has a fifty day moving average price of $276.61 and a 200-day moving average price of $330.51. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market capitalization of $36.63 billion, a PE ratio of 26.94, a PEG ratio of 2.35 and a beta of 0.52. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts expect that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.16%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.